ReportGemReportGem 中文

PUBLIC COMPANY RESEARCH HUB

4543 (4543) Foreign Research Coverage

A focused collection of foreign research coverage for 4543, organized by institution and publication date for faster discovery.

Evidence documents4
Filings0
Meetings0
Research4
Displayed research share100%
Latest evidence2026-08-20

Foreign research

テルモ (4543.T) CSLとHaemoneticsの件についてのセルサイドコール。不透明要因多いが、大きな影響はないと予想2026-08-20 · CitiTerumo (4543.T): Holds sell-side call on CSL, Haemonetics – lots of uncertainties but we do not anticipate a big impact2026-08-20 · Citi日本ライフサイエンス・診断.メディックとヘルステック・流通: 2026年4-6月決算レビュー:メディック好調な01。Q2では上方修正出そう。朝日インテックがドンブツピック2026-08-20 · CitiJapan Medtech: April-June 2026 review - expect Q2 upward revisions in medtech following strong Q1, top pick Asahi Intecc2026-08-20 · Citi

Questions this evidence can help answer

  • What changed in the latest research coverage of 4543?
  • Which operating and valuation themes recur across institutions?
  • Which claims should be checked against company primary-source evidence?
Research this company with AI